KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$5.90 USD
-0.16 (-2.64%)
Updated Aug 28, 2024 01:57 PM ET
After-Market: $5.96 +0.06 (1.02%) 7:48 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Brokerage Reports
KALA BIO, Inc. [KALA]
Reports for Purchase
Showing records 341 - 360 ( 367 total )
Company: KALA BIO, Inc.
Industry: Unclassified
Q2 Financials; We Anticipate INVELTYS Approval by August 24 PDUFA
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
STRIDE 3 Dry Eye Trial Starts Patient Dosing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: KALA BIO, Inc.
Industry: Unclassified
A New View on Ocular Drug Delivery; Initiating at Buy and $35 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
Dry Eye Program Advancing on Schedule with Concurrent Review and Trial
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Clarity on Dry Eye Program in Late Q2/Q3 and INVELTYS August 24 PDUFA
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
Corporate Update in Front of Important 2018 Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
Company: KALA BIO, Inc.
Industry: Unclassified
Dry Eye Potentially Approvable--Next Steps Midyear; Surgery Moves Into Review
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
Week Ahead
Provider: WEDBUSH SECURITIES INC.
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: KALA BIO, Inc.
Industry: Unclassified
Down to the Wire: Preview of Two Imminent Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Unclassified
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D